{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "37863031",
  "DateCompleted": {
    "Year": "2023",
    "Month": "10",
    "Day": "27"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "11",
    "Day": "03"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.chembiol.2023.09.002",
      "S2451-9456(23)00290-8"
    ],
    "Journal": {
      "ISSN": "2451-9448",
      "JournalIssue": {
        "Volume": "30",
        "Issue": "10",
        "PubDate": {
          "Year": "2023",
          "Month": "Oct",
          "Day": "19"
        }
      },
      "Title": "Cell chemical biology",
      "ISOAbbreviation": "Cell Chem Biol"
    },
    "ArticleTitle": "A new chink in cancer's armor: Unleashing cell death by selective PP5 inhibition.",
    "Pagination": {
      "StartPage": "1186",
      "EndPage": "1188",
      "MedlinePgn": "1186-1188"
    },
    "Abstract": {
      "AbstractText": [
        "Serine/threonine protein phosphatases play a significant role in the survival and propagation of multiple cancers. In this issue of Cell Chemical Biology, Ahanin et\u00a0al.<sup>1</sup> demonstrate that protein phosphatase 5 (PP5) dephosphorylates and inactivates the cell death effector protein FADD independently of Hsp90, and they identify a selective PP5 inhibitor as a new therapeutic strategy for renal cancer."
      ],
      "CopyrightInformation": "Copyright \u00a9 2023 Elsevier Ltd. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Biological Sciences, University of North Carolina at Charlotte, Charlotte, NC 28223, USA. Electronic address: pvanoost@charlotte.edu."
          }
        ],
        "LastName": "van Oosten-Hawle",
        "ForeName": "Patricija",
        "Initials": "P"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Comment"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Cell Chem Biol",
    "NlmUniqueID": "101676030",
    "ISSNLinking": "2451-9448"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "EC 3.1.3.16",
      "NameOfSubstance": "protein phosphatase 5"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "tissue-factor-pathway inhibitor 2"
    },
    {
      "RegistryNumber": "EC 3.1.3.16",
      "NameOfSubstance": "Phosphoprotein Phosphatases"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Nuclear Proteins"
    }
  ],
  "CommentsCorrectionsList": [
    {
      "RefSource": "Cell Chem Biol. 2023 Oct 19;30(10):1223-1234.e12",
      "PMID": "37527661"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Phosphoprotein Phosphatases"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Nuclear Proteins"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Cell Death"
    },
    {
      "QualifierName": [
        "drug therapy"
      ],
      "DescriptorName": "Neoplasms"
    }
  ],
  "CoiStatement": "Declaration of interests The author declares no competing interests."
}